Scholar Rock Holding (SRRK) Free Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -4.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.08% |
| Dec 31, 2025 | -52.47% |
| Sep 30, 2025 | -31.48% |
| Jun 30, 2025 | -56.73% |
| Mar 31, 2025 | -58.53% |
| Dec 31, 2024 | -32.63% |
| Sep 30, 2024 | -62.63% |
| Jun 30, 2024 | -51.05% |
| Mar 31, 2024 | -15.58% |
| Dec 31, 2023 | -25.08% |
| Sep 30, 2023 | -25.70% |
| Jun 30, 2023 | 7.53% |
| Mar 31, 2023 | -0.25% |
| Dec 31, 2022 | 9.51% |
| Sep 30, 2022 | 35.89% |
| Jun 30, 2022 | -16.96% |
| Mar 31, 2022 | -48.94% |
| Dec 31, 2021 | -52.35% |
| Sep 30, 2021 | -58.76% |
| Jun 30, 2021 | -49.93% |
| Mar 31, 2021 | -1,198.86% |
| Dec 31, 2020 | -23.50% |
| Sep 30, 2020 | -50.78% |
| Jun 30, 2020 | -26.02% |
| Mar 31, 2020 | 116.40% |
| Dec 31, 2019 | -132.24% |
| Sep 30, 2019 | -74.05% |
| Jun 30, 2019 | -35.11% |
| Mar 31, 2019 | -61.80% |
| Dec 31, 2018 | 955.24% |
| Sep 30, 2018 | -71.80% |